Taysha Gene Therapies, Inc.is a patient-centric, clinical-stage gene therapy company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing. The company was founded by Steven Gray, Berge Minassian, and R. A. Session II in 2019 and is headquartered in Dallas, TX.

CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing innovative therapeutics and pharmaceutical products. The firm is also involved in developing innovative therapeutics addressing cancer and other unmet medical needs for the global market. The company was founded in 1991 and is headquartered in Beijing, China.

Schmid Group NV engages in the provision of equipment and services for various industries such as printed circuit board, substrate manufacturing, photovoltaics, and glass and energy storage with a focus in terms of technology and performance such as automation, wet processes, and vacuum processes. The company is headquartered in Freudenstadt, Germany.

Gulf Island Fabrication, Inc. engages in the business of fabricating complex steel structures and modules and the provision of specialty services. It operates through the following segments: Services, Fabrication, Shipyard, and Corporate. The Services segment provides maintenance, repair, construction, scaffolding, coatings, and welding enclosures on offshore platforms and inland structures and at industrial facilities. The Fabrication segment fabricates modules, skids, and piping systems for onshore refining, petrochemical, liquefied natural gas, and industrial and offshore facilities. The Shipyard segment includes divested shipyard contracts and facility. The Corporate segment focuses on the costs of maintaining corporate office, executive management salaries and incentives, board of directors' fees, certain insurance costs, and costs associated with overall corporate governance and reporting requirements. The company was founded by Alden J. Laborde in 1985 and is headquartered in The Woodlands, TX.

Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in San Carlos, CA.

ViaSat, Inc. engages in providing communications technologies and services. It operates through the following business segments: Satellite Services, Commercial Networks, and Government Systems. The Satellite Services segment provides satellite-based high-speed broadband services with multiple applications to consumers, enterprises, and mobile broadband customers. The Commercial Networks segment develops and produces a variety of advanced satellite and wireless products, systems, and solutions that enable the provision of high-speed fixed and mobile broadband services. The Government Systems segment offers global mobile broadband services to military, and government users and develops and produces network-centric Internet Protocol (IP)-based fixed and mobile secure communications products and solutions. The company was founded by Mark D. Dankberg and Mark J. Miller on May 1, 1986 and is headquartered in Carlsbad, CA.

MicroStrategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Techprecision Corp. engages in the business of metal fabrication and precision machining. It focuses on the manufacture of precision, large-scale fabricated and machined metal components and systems. The company was founded by Andrew A. Levy in February 2005 and is headquartered in Westminster, MA.

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.

CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC). The company was founded by Alex Yeung and Paul A. DeRidder on September 24, 2010 and is headquartered in Irvine, CA.